Actualités sur Health

27.02.2017 – 14:49
ALK
ALK's ACARIZAX® Data Results in Significant Change to the GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended as a Treatment Option in Patients With House Dust Mite Allergic Asthma
Hørsholm, Denmark (ots/PRNewswire) - ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention. This global strategy is a ...
plus
24.02.2017 – 14:06
Merck Healthcare Germany GmbH
Merck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - Ready-to-use pre-filled pen provides a convenient treatment option for patients - Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European ...
plus
24.02.2017 – 13:19
Shire Pharmaceuticals Group Plc
CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
plus
23.02.2017 – 14:02
Tillotts Pharma AG
Tillotts Pharma in Germany Dedicated to Gastrointestinal Health
Berlin (ots/PRNewswire) - Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn's disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With ...
plus
22.02.2017 – 17:17
Royal Philips
Philips Reinforces Leadership in Image-guided Therapy Solutions with Global Launch of Next Generation Azurion Platform
Amsterdam (ots/PRNewswire) - - Developed in collaboration with leading hospitals worldwide, Philips Azurion (https://www.usa.philips.com/healthcare/resources/landing/azurion) is an innovative image-guided therapy platform that allows clinicians to easily and confidently perform a wide range of routine and complex ...
plus
14.02.2017 – 00:59
Janssen Sciences Ireland UC
Janssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Maintaining Viral Suppression in Phase III Clinical Studies
Seattle (ots/PRNewswire) - - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC (Janssen) announced positive results ...
plus
09.02.2017 – 11:03
Merck Healthcare Germany GmbH
Cladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - Post hoc analysis of Phase III CLARITY study data recently published in Multiple Sclerosis Journal showed statistically significant reduction in brain atrophy in patients on a short course of investigational Cladribine Tablets over two years compared with patients receiving placebo - These findings correlated with effects on ...
plus
01.02.2017 – 19:38
Shire Pharmaceuticals Group Plc
New Data From Shire Aim To Help Close the Diagnosis and Treatment Gap for People With Hemophilia
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
plus
01.02.2017 – 08:02
Novo Nordisk
Flexible Storage Options can Impact Daily Use of FVIII Treatments in People with Haemophilia A
Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
plus
31.01.2017 – 14:03
Kantar TNS and Nestlé Waters
Kantar TNS Survey for Nestle Waters on Water Consumption
Paris (ots/PRNewswire) - Water needs is a common ground across populations and cultures according to the survey but local habits and knowledge still affect water consumption Kantar TNS and Nestle Waters published a survey on attitudes about water consumption in seven countries: China, France, Italy, Mexico, the UK, the US and Turkey. To view the Multimedia News Release, please click: ...
plus
27.01.2017 – 14:48
Jacoti bvba
Jacoti Named as Global Mobile Awards 2017 Nominee for the Best Use of Mobile for Accessibility & Inclusion Category
Wevelgem, Belgium (ots/PRNewswire) - Jacoti Hearing Suite, an innovative set of hearing applications created by Jacoti bvba, has been named a Global Mobile Awards 2017 Nominee. Products entered in this prestigious program are judged by a preeminent panel of more than 250 independent judges from across the world, ...
plus
27.01.2017 – 08:41
Allergan plc
Allergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months
Dublin (ots/PRNewswire) - -- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] -- Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine lines), hydration and elasticity for up to nine months ...
plus
23.01.2017 – 13:01
Resverlogix Corp.
Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
Calgary, Alberta (ots/PRNewswire) - Several Key Proteins That Drive Kidney (Renal) Disease and Dialysis Risk are Downregulated After a Single Dose of Apabetalone Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced preliminary results from the New Zealand based Phase 1 trial with severe kidney (renal) impaired patients. The data showed ...
plus
20.01.2017 – 11:43
Merck Healthcare Germany GmbH
Merck and Genea Open Centre of Excellence for Fertility
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading science and technology company, today announced the opening of its first Centre of Excellence (CoE) ...
plus
17.01.2017 – 17:32
International Union Against Cancer (UICC)
Sectors Converge to Change the Future of Cancer in Urban Populations
Davos, Switzerland (ots/PRNewswire) - - New city-level initiative launched in partnership between the Union for International Cancer Control (UICC), the World Economic Forum and World Bank - A commitment to saving lives by helping country and city leaders improve the health of their citizens and reduce inequities in access to quality cancer treatment and care - A ...
plus
06.01.2017 – 07:01
DS Biopharma
DS Biopharma (DS) Announces that Recruitment has Begun in Two Separate Phase 2b Atopic Dermatitis Studies with Lead Compound DS107 as well as the Successful Completion of a Phase 1 trial for Follow on Compound DS109
Dublin (ots/PRNewswire) - DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in two separate Phase 2b atopic dermatitis (AD) studies with its lead compound DS107. An Oral DS107 Phase 2b study (called 'ADvance') in 300 ...
plus
20.12.2016 – 13:02
InSightec
The Japanese Ministry of Health, Labor and Welfare Approved Exablate Neuro System for the Treatment of Essential Tremor
Tokyo and Haifa, Israel (ots/PRNewswire) - INSIGHTEC (http://www.insightec.com/JP/), the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in ...
plus
20.12.2016 – 11:02
Accuray Europe
Treatment with the TomoTherapy® System Concurrent with Systemic Medication Improves Progression-Free Survival in Patients with Solitary Plasmacytoma of the Bone
Sunnyvale, California (ots/PRNewswire) - Practice-Changing Study Presented at the 2016 Best of ASTRO Meeting Accuray Incorporated (NASDAQ: ARAY) announced today new data showing that 80 percent of patients with solitary plasmacytoma of the bone (SPB) had excellent cancer control four years after receiving ...
plus
16.12.2016 – 12:01
Grünenthal Group
Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of CRPS
Aachen / Pisa (ots) - Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome (CRPS), a debilitating orphan disease with high medical need - Neridronic acid is the first investigational medicine to receive Breakthrough Therapy ...
plus
16.12.2016 – 10:01
Global Kinetics
Global Kinetics and uMotif Announce Technology Partnership for Parkinson's Trials
London (ots/PRNewswire) - Global Kinetics Corporation (http://www.globalkineticscorporation.com/) and uMotif (https://www.umotif.com/) have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease. Bringing together leading proprietary products, the Global ...
plus
14.12.2016 – 14:02
Tillotts Pharma AG
Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Launches Zentacort® 3mg Capsules in Japan for Treatment in Crohn's Disease
Rheinfelden, Switzerland (ots/PRNewswire) - Zeria Pharmaceutical Co., Ltd launched Zentacort® 3mg capsules (generic name: Budesonide) in Japan on November 29, 2016. Zentacort® is sold as Entocort(TM) in more than 40 countries and recommended as first line therapy for treatment in Crohn's Disease (CD) in various ...
plus
12.12.2016 – 08:01
Astellas Pharma EMEA
Astellas Announces Transfer of Qutenza(TM) to Grünenthal
Tokyo and Chertsey, England (ots/PRNewswire) - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas"), today announced that Astellas Pharma Europe Ltd., ("Astellas Pharma Europe") has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza(TM) (capsaicin 8% patch) in Europe, Middle East and Africa to Grünenthal. (Logo: ...
plus
08.12.2016 – 13:02
Daiichi Sankyo Europe GmbH
Daiichi Sankyo Announces Initiation of Real-World Study in LIXIANA® (edoxaban) Patients Undergoing Diagnostic and Therapeutic Procedures in NVAF and VTE
Munich (ots/PRNewswire) - First patient enrolled in EMIT-AF/VTE study (NCT02950168), a European registry to assess edoxaban management in patients undergoing medical procedures[1] Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced that the first patient has been enrolled in the EMIT-AF/VTE ...
plus
08.12.2016 – 12:31
Accuray Europe
First Cancer Patients in the World Treated with the Smart, New Accuray Radixact(TM) System
Sunnyvale, California (ots/PRNewswire) - European and U.S. Hospitals Advance Adaptive Cancer Care with Image-Guided Radiation Therapy System Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact(TM) Treatment Delivery System, fully integrated with the new Accuray ...
plus
07.12.2016 – 11:57
HOYA Vision Care
HOYA Vision Care Announces Agreement to Acquire Safety Prescription Eyewear Business from 3M
Uithoorn, The Netherlands (ots/PRNewswire) - Acquisition provides HOYA Vision Care access to an important new market HOYA Vision Care, a division of HOYA Group (HOYA) today announced a definitive agreement to acquire the safety prescription eyewear business of 3M. This safety prescription eyewear business is an ...
plus
05.12.2016 – 14:29
Helsinn Healthcare SA
Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Lugano, Switzerland and San Diego (ots/PRNewswire) - Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016 Global Phase 3 study site recruitment is ongoing Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, ...
plus
03.12.2016 – 18:01
Novo Nordisk
NovoSeven® Resolved 96.5% of Bleeds When Initiated Within One Hour After Bleed Onset in People With Haemophilia A or B With Inhibitors
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced that NovoSeven® (rFVIIa), a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds when ...
plus
02.12.2016 – 09:02
Novo Nordisk
Xultophy® Demonstrates Similar Glucose Control with Reduced Risk of Hypoglycaemia and a Superior Weight Profile Compared to Basal-Bolus Therapy
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced new phase 3b trial (DUAL VII) results with Xultophy® (IDegLira). Xultophy® is a once-daily, single injection fixed combination ...
plus
30.11.2016 – 12:33
Leica Biosystems Ltd
Expanded Options for Cancer Researchers with Leica Biosystems and Advanced Cell Diagnostics Automated RNA ISH Workflow with Powerful Aperio Image Analysis*
Vista, California (ots/PRNewswire) - * Aperio RNA ISH Algorithm and BOND RX are for Research Use Only. Not for use in diagnostic procedures. Leica Biosystems and Advanced Cell Diagnostics (ACD) - a Bio-Techne brand, proudly announce the availability of the Aperio RNA ISH ...
plus
29.11.2016 – 14:24
Merck Healthcare Germany GmbH
FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - If approved by the FDA, avelumab, an investigational immunotherapy, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma (MCC) - Avelumab has previously received FDA Breakthrough Therapy and Fast ...
plus

Précédent29303132333435363738Suivant